Skip to content

Tender notice

Health by Design Assurance Methodology

Notice details

Published
Category
services
Buyer region
West Midlands

Public buyer

Public buyer

HS2

Tender value£160,000

  1. Planned start
    As published in the notice
  2. Planned end
    As published in the notice

Work description

HS2's construction contractors have been required to implement a 'health by design' methodology to support HS2's Safe at Heart health commitments. This will run parallel with Safe by Design as a requirement under CDM 2015. There will be a joint approach to the use of BIM, especially in relation to the H&S File.

Safe by Design is an established industry practice, whereas Health by Design is not. Therefore, a discovery exercise is required to define a methodology and mapping exercise to support how HS2 will assure the supply chain's implementation of its Health by Design commitments.

There is also a requirement to identify how HS2 will future proof the methodology using technologies such as BIM and to define how HS2 will calculate whole life health costs.

Once the assurance methodology and mapping exercise have been defined, a programme of training and education will need to be developed and delivered to the construction, engineering and costing managers at HS2.

To deliver against these requirements, HS2 will be inviting tenders for two consecutive contracts:

• Health by Design Phase 1: Discovery phase - develop the methodology and design and deliver training for HS2 staff.

• Health by Design Phase 2: Build phase - build the Tools required to support the Health by Design assurance methodology.

This invitation to tender is for Health by Design Phase 1.

HS2 intends to invite tenders for Health by Design Phase 2 later this year.

Additional information: To express an interest in this contract and to access the ITT documents, please register with HS2's e-sourcing portal at https://hs2.bravosolution.co.uk/web/login.html.

Related awards

Source: Contracts Finder · Notice 6a1828df-e828-4ca0-b6a4-f897308ad339-143236

View source notice